Prognostic value of 6-Min Walk Test (6MWT) in Patients with non-Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
G. Jeanniard (Nantes, France), M. Nasser (Lyon, France), S. Turquier (Lyon, France), K. Ahmad (Lyon, France), J. Calabuig Lopez (Lyon, France), J. Glérant (Lyon, France), J. Traclet (Lyon, France), A. Chambellan (Nantes, France), V. Cottin (Lyon, France)
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Jeanniard (Nantes, France), M. Nasser (Lyon, France), S. Turquier (Lyon, France), K. Ahmad (Lyon, France), J. Calabuig Lopez (Lyon, France), J. Glérant (Lyon, France), J. Traclet (Lyon, France), A. Chambellan (Nantes, France), V. Cottin (Lyon, France). Prognostic value of 6-Min Walk Test (6MWT) in Patients with non-Idiopathic Pulmonary Fibrosis Progressive Fibrosing Interstitial Lung Disease (PF-ILD). 2244
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: